Vol. 286, Issue 3, 1427-1430, September 1998
Protective Effect of Bismuth Nitrate Against Injury to the Bone
Marrow by
-Irradiation in Mice: Possible Involvement of Induction of
Metallothionein Synthesis1
Nobuhiko
Miura,
Masahiko
Satoh,
Nobumasa
Imura and
Akira
Naganuma
Department of Molecular and Biochemical Toxicology, Faculty of
Pharmaceutical Sciences, Tohoku University, Aoba-ku, Sendai 980-8578, Japan (N.M., A.N.);
Department of Public Health and Molecular
Toxicology, School of Pharmaceutical Sciences, Kitasato University,
Minato-Ku, Tokyo 108-8641, Japan (N.I.); and
Environmental Health
Sciences Division, National Institute for Environmental Studies
Tsakuba, Ibavaki, 305-0053, Japan (M.S.)
 |
Abstract |
The effects of bismuth nitrate (BN) on the lethal effect of and injury
to bone marrow by
-irradiation were examined. Mice were given daily
s.c. injections of BN for 2 days and were exposed to whole-body
irradiation (137Cs; 8 grays) 24 hr after the second
injection of BN. All mice exposed to
-irradiation without treatment
with BN died within 30 days, but the lethal effect of
-irradiation
was markedly reduced in mice given BN before irradiation. Irradiation
(3 grays) significantly reduced the total number of leukocytes 1 day
after irradiation but the number of leukocytes subsequently increased
in both nontreated and BN-treated irradiated mice. However, the rate of
recovery of the total number of leukocytes, as monitored from 5 days
after irradiation, was significantly higher in BN-treated mice than in
the nontreated mice. Reductions in the viability of hematopoietic stem
cells (determined by monitoring the number of colony-forming units in
the spleen) that were induced by
-irradiation (3 grays) were
considerably diminished by the treatment of mice with BN before
irradiation. BN significantly increased the concentration of
metallothionein in the bone marrow cells of mice, but levels of other
cellular antioxidants, such as catalase, superoxide dismutase, glutathione-S-transferase, glutathione peroxidase and glutathione, were
unchanged. These results suggest that BN protects bone marrow cells
against the toxic effects of
-irradiation by inducing the synthesis
of metallothionein in the bone marrow. Metallothionein might play an
important role in determining the sensitivity of animals to
-irradiation.
 |
Introduction |
MT
is a metal-binding protein of low molecular weight, and one-third of
its amino acids are cysteine residues (Webb, 1979
). The synthesis of MT
can be induced by various metals, by xenobiotics and by different types
of stress (Kägi, 1991
; Sato and Bremner, 1993
; Webb, 1979
). MT
appears to be a multifunctional protein that plays a role in the
detoxification of metal compounds and several xenobiotics, in the
homeostasis of essential metals, such as zinc and copper, and in the
scavenging of reactive oxygen species (Bremner, 1987
; Kägi, 1991
;
Sato and Bremner, 1993
; Webb, 1979
).
Ionizing radiation generates free radicals in the living cells (Chapman
and Gillespie, 1981
) and induces injury to the bone marrow (Henshke and
Morton, 1957
). We reported previously that decrease in the total number
of leukocytes in the peripheral blood observed in mice exposed to
-irradiation was significantly protected by prior treatment of mice
with bismuth compounds (Satoh et al., 1989
) which is one of
inducers of MT synthesis (Naganuma et al., 1987
). In this
study, we investigated the possible involvement of MT in the protective
effects of BN on the
-irradiation-induced decrease in the total
number of leukocytes in mice.
 |
Materials and Methods |
Animals and chemicals.
Male ICR mice (6 wk old) were
purchased from Charles River Japan, Inc. (Atsugi, Japan). Male
B6D2F1 mice (6 wk old) were purchased from Japan SLC
(Hamamatsu, Japan). BN was purchased from Kanto Chemical Co., Inc.
(Tokyo, Japan) and dissolved in distilled water. [203Hg]-HgCl2 (2.4 mCi/mg) was purchased from
New England Nuclear (Boston, MA). Other chemicals were purchased from
Wako Pure Chemical Industries, Ltd. (Tokyo, Japan).
Treatment of animals.
ICR mice received injections s.c. with
50 or 100 µmol/kg BN once a day for 2 days. Then, 24 hr after the
last injection (in most experiments), mice were exposed to whole-body
-irradiation (137Cs; 3 or 8 grays) from a Gamma Cell 40 (Atomic Energy of Canada Ltd., Ontario, Canada) at a dose rate of 1.117 grays/min.
Assay of CFU-S.
To determine the number of multipotential
hematopoietic stem cells, we determined numbers of CFU-S as described
by Till and McCulloch (1961)
. The donor mice (B6D2F1)
received injections s.c. with 100 µmol/kg BN once a day for 2 days
and then exposed to
-irradiation (3 grays) 24 hr after the second
injection of BN. The marrow cells of these mice were isolated 1 day
after the
-irradiation and suspended in saline. The number of
nucleated cells among the marrow cells was determined after addition of Turk's reagent. Suspensions of cells were kept on ice before injection into recipient mice. Recipient B6D2F1 mice were exposed
-irradiation (9 grays) and then the marrow cells obtained from the
donor mice were transplanted i.v. The recipient mice were killed 10 days after transplantation. Their spleens were removed and fixed in Bouin's solution, and then the number of colonies in each spleen was
determined.
Analysis of cellular factors.
Bone marrow cells were
collected from mice, suspended in saline and then sonicated. The
activities of antioxidant enzymes in the samples were determined
spectrophotometrically. Activities of catalase and SOD were determined
by the methods of Cohen et al. (1970)
and Imanari et al.
(1977)
, respectively. The activity of GSH-Px was determined by the
method of Lawrence and Burk (1976)
, with cumene hydroperoxide and
hydrogen peroxide as substrates. The activity of GST was determined by
the method of Habig et al. (1974)
with
1-chloro-2,4-dinitrobenzene as substrate. The concentration of MT in
the bone marrow was determined by a 203Hg-binding assay
(Naganuma et al., 1987
). The concentration of GSH was
determined by method of Tanaka-Kagawa et al. (1993)
by high-performance liquid chromatography. The concentration of protein was determined by the method of Lowry et al. (1951)
with bovine serum
albumin as the standard. The total number of leukocytes in the blood of
mice was counted with a Coulter counter.
Northern blot analysis.
Mice received injections s.c. with
BN (100 µmol/kg) once a day for 2 days. Twelve hours after the second
injection of BN, the bone marrow cells and kidney were removed. Total
RNA were extracted and the RNA samples (20 µg/lane) were separated by
electrophoresis on 1% agarose/formaldehyde gels, transferred to nylon
membrane (NYTRAN, Schleicher & Schuell, Inc., Keene, NH), and UV
cross-linked. DIG-labeled mouse MT-I and GAPDH (as an internal control)
cDNA probes were generated using the PCR (polymerase chain reaction) DIG probe synthesis kit (Boehringer Mannheim, Mannheim, Germany) according to the manufacture's instructions. Hybridization, washing and detection were performed using DIG luminescent detection kit (Boehringer Mannheim, Mannheim, Germany) and membrane was exposed to
x-ray film for about 1 hr at room temperature.
 |
Results |
Table 1 shows the effects of
treatment of mice with BN on the lethality of subsequent
-irradiation (137Cs; 8 grays). Mice were given an
injection of BN once a day for 2 days and received whole-body
-irradiation 24 hr after the second injection of BN. All mice
exposed to
-irradiation without prior treatment with BN died within
30 days. The lethal effect of
-irradiation was markedly diminished
by prior treatment with BN and the effect of BN was dose dependent.
This protective effect of BN against the lethality of
-irradiation
was observed only when BN was administered prior to the
-irradiation
(table 2). Figure
1 shows the effects of prior treatment
with BN on irradiation-induced injury to bone marrow, as indicated by
decreases in total numbers of leukocytes. In this experiment, mice
received whole-body irradiation from 137Cs at a dose of 3 grays, which was toxic but not lethal. A marked reduction in the total
of number of leukocytes was observed 1 day after irradiation and
subsequently the number of leukocytes was increased gradually in
irradiated mice with and without prior treatment with BN. However, the
rate of the recovery of the total number of leukocytes, monitored from
5 days after irradiation, in BN-treated irradiated mice was
significantly higher than that in the nontreated irradiated mice.
View this table:
[in this window]
[in a new window]
|
TABLE 2
Effects of the schedule for administration of bismuth nitrate (BN) on
the lethality of -irradiation in mice
|
|

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 1.
Effects of treatment with bismuth nitrate (BN) on the
total number of leukocytes in mice after subsequent -irradiation.
Mice received injections s.c. with 100 µmol/kg of BN or saline once a
day for 2 days. They received whole-body irradiation
(137Cs; 3 grays) 24 hr after the second injection of BN.
Each value represents the mean ± S.D. of four mice.
* Significantly different from untreated irradiated mice (P < .025).
|
|
To examine the effect of prior treatment with BN on bone marrow cells,
we investigated the viability of hematopoietic stem cells by
determining number of CFU-S (Till and McCulloch, 1961
). The number of
colonies formed in spleens of recipient mice 10 days after
transplantation of marrow cells obtained from the donor mice after
exposure to
-rays (3 grays) was about 1% of that in the case of
unirradiated control mice (fig. 2).
Treatment with BN before
-irradiation increased the number of CFU-S
to about six times that in the case of BN-untreated irradiated mice
(fig. 2). The sizes of the colonies that formed in spleens of recipient mice that had received injections with marrow cells from donor mice
after
-irradiation without BN-treatment were also significantly smaller than when donor cells came from control mice. However, the
sizes of colonies formed in spleens of recipient mice that received
injections of marrow cells from mice exposed to
-rays after prior
treatment with BN was almost the same as that in the case of the
control mice (data not shown). These results suggested the possibility
that treatment of mice with BN before irradiation protected the bone
marrow cells against the toxic effects of
-irradiation by scavenging
reactive oxygen species because
-irradiation is known to increase
the rate of generation of reactive oxygen species in living cells
(Chapman and Gillespie, 1981
) and to induce injury to the bone marrow
(Henshke and Morton, 1957
).

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 2.
Effects of bismuth nitrate (BN) on the viability of
hematopoietic stem cells, as determined by an assay of colony-forming
units in the spleen (CFU-S). Mice received injections s.c. with BN (100 µmol/kg) once a day for 2 days and received whole-body irradiation
(137Cs; 3 grays) 24 hr after the second injection of BN.
One day after -irradiation, surviving stem cells were examined by
the CFU-S assay (see text for details). Each value represents the
mean ± S.D. of four mice. * Significantly different from
untreated irradiated mice (P < .001).
|
|
Table 3 shows the effects of treatment
with BN on the activity or concentration of various cellular factors
that act as antioxidants in bone marrow cells. Mice were given BN once
a day for 2 days and then levels of antioxidant factors were determined
24 hr after the second dose of BN at 100 µmol/kg. BN significantly
increased the concentration of MT in the bone marrow cells. However, no significant changes in the activities of catalase, SOD, GST and GSH-Px
and the concentration of GSH were observed (table 3). Induction of MT
synthesis in the bone marrow cells by BN was also confirmed by an
increase in MT-I mRNA levels (fig. 3).
View this table:
[in this window]
[in a new window]
|
TABLE 3
Activities of glutathione-S-transferase (GST), superoxide dismutase
(SOD), catalase and glutathione peroxidase (GSH-Px) and the
concentrations of metallothionein (MT) and glutathione (GSH) in bone
marrow cells of mice treated with bismuth nitrate (BN)
|
|

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 3.
Northern blot analysis of MT-I mRNA levels in the
bone marrow cells and kidney of mice treated with bismuth nitrate (BN).
Mice received injections s.c. with BN (100 µmol/kg) once a day for 2 days. Twelve hours after the second injection of BN, the bone marrow
cells and kidney were removed. Northern hybridization was performed
using digoxigeninlabeled mouse MT-I and GAPDH cDNA probe.
|
|
 |
Discussion |
We previously observed that the decrease in the total number of
leukocytes in the peripheral blood, monitored in mice 10 days after
-irradiation, could be limited by prior treatment of mice with a
bismuth compound (Satoh et al., 1989
). In our study, prior treatment with BN did not affect the decrease in the total number of
leukocytes determined 1 day after
-irradiation (fig. 1). However, the return to normal values of the reduced total number of leukocytes, monitored from 5 days after the
-irradiation, was more rapid in
BN-treated mice than in untreated mice (fig. 1). This result indicates
that the protective effects of bismuth compounds that we had observed
previously (Satoh et al., 1989
) were not due to protection
of leukocytes in the peripheral blood by such compounds. However,
significant protection of bone marrow cells against
-irradiation was
apparent in mice that had been treated with BN before irradiation (fig.
2). These results suggest that prior treatment with BN accelerates the
recovery of number of leukocytes in the peripheral blood by protecting
the bone marrow against
-irradiation.
Treatment of mice with BN had a significant protective effect against
lethality of
-irradiation, but such protection was observed only
when BN was administered prior to
-irradiation (tables 1 and 2).
Thus, the possibility exists that prior treatment with BN induced
synthesis of certain cellular factors that can protect the bone marrow
against the reactive oxygen species generated by
-irradiation.
Bismuth compounds are known to induce the synthesis of MT via the
activation of a metal-response element that is located in the
5'-upstream region of the gene for MT (Palmiter, 1994
; Searle et
al., 1985
). Thornalley and Vasak (1985)
noted that MT efficiently eliminates reactive oxygen species, and the rate of reaction of MT with
hydroxy radicals is several hundred-fold higher than that of GSH.
Moreover, protective effect of MT against DNA damage induced by
hydrogen peroxide (Chubatsu and Meneghini, 1993
), nitric oxide (Schwarz
et al., 1995
) or cadmium (Cai et al., 1995
;
Chubatsu and Meneghini, 1993
) has been reported. BN significantly
increased the mRNA (fig. 3) and protein levels (table 3) of MT in the
bone marrow cells of mice without any effects on activities or levels of other cellular antioxidants such as catalase, SOD, GST, GSH-Px and
GSH (table 3). In this experiment, the elevated concentration of MT in
the bone marrow caused by treatment with BN was only about twice the
control level. In an earlier study of the heart, at only about twice
the control level of MT, the peroxidation of cardiac lipid induced by
adriamycin was found to be strongly suppressed (Naganuma et
al., 1988
). These results suggest that BN might protect bone
marrow cells against the toxic effects of
-irradiation by inducing
the synthesis of MT in the bone marrow. MT is a strongly inducible
protein and its concentration in tissues is increased by different
types of stress (Sato and Bremner, 1993
). Thus, MT might play an
important role in determining the sensitivity of animals to
-irradiation.
 |
Footnotes |
Accepted for publication April 16, 1998.
Received for publication January 26, 1998.
1
This work was supported by a Grant-in-Aid for Cancer
Research from the Ministry of Education, Science, Sports and Culture of
Japan.
Send reprint requests to: Dr. Akira Naganuma, Department of
Molecular and Biochemical Toxicology, Faculty of Pharmaceutical
Sciences, Tohoku University, Aoba-ku, Sendai 980-8578, Japan.
 |
Abbreviations |
MT, metallothionein;
BN, bismuth nitrate;
GSH, glutathione;
SOD, superoxide dismutase;
GSH-Px, glutathione peroxidase;
GST, glutathione-S-transferase;
CFU-S, colony-forming units in the
spleen;
DIG, digoxigenin.
 |
References |
-
Bremner I
(1987)
Nutritional and physiological significance of metallothionein, in
Metallothionein II, Experientia Suppl. (Kägi JHR andKojima Y eds) pp 81-107,
Birkhauser Verlag, Basel, Switzerland.
-
Cai L,
Koropatnick J and
Cherian MG
(1995)
Metallothionein protects DNA from copper-induced but not iron-induced cleavage in vitro.
Chem Biol Interact
96:
143-155[Medline].
-
Chapman JD and
Gillespie CJ
(1981)
Radiation-induced events and their time scale in mammalian cells.
Adv Radiat Biol
9:
143-198.
-
Chubatsu LS and
Meneghini R
(1993)
Metallothionein protects DNA from oxidative damage.
Biochem J
291:
193-198.
-
Cohen G,
Dembiec D and
Marcus J
(1970)
Measurement of catalase activity in tissue extracts.
Anal Biochem
34:
30-38[Medline].
-
Habig WH,
Pabst MJ and
Jakoby WB
(1974)
Glutathione S-transferases: The first enzymatic step in mercapturic acid formation.
J Biol Chem
249:
7130-7139[Abstract/Free Full Text].
-
Henshke UK and
Morton JL
(1957)
Mortality of rhesus monkeys after single total irradiation.
Am J Roentgenol Radiat Ther
77:
899-909.
-
Imanari T,
Hirota M and
Miyazaki M
(1977)
Improved assay method for superoxide dismutase.
J Clin Exp Med
101:
496-497.
-
Kägi JH
(1991)
Overview of metallothionein.
Methods Enzymol
205:
613-626[Medline].
-
Lawrence RA and
Burk RF
(1976)
Glutathione peroxidase activity in selenium-deficient rat liver.
Biochem Biophys Res Commun
71:
952-958[Medline].
-
Lowry OH,
Rosebrough NJ,
Farr AL and
Randall RJ
(1951)
Protain measurement with the Folin phenol reagent.
J Biol Chem
193:
265-275[Free Full Text].
-
Naganuma A,
Satoh M and
Imura N
(1987)
Prevention of lethal and renal toxicity of cis-diamminedichloroplatinum (II) by induction of metallothionein synthesis without compromising its antitumor activity in mice.
Cancer Res
47:
983-987[Abstract/Free Full Text].
-
Naganuma A,
Satoh M and
Imura N
(1988)
Specific reduction of toxic side effects of adriamycin by induction of metallothionein in mice.
Jpn J Cancer Res
79:
406-411[Medline].
-
Palmiter RD
(1994)
Regulation of metallothionein genes by heavy metals appears to be mediated by a zinc-sensitive inhibitor that interacts with a constitutively active transcription factor, MTF-1.
Proc Natl Acad Sci USA
91:
1219-1223[Abstract/Free Full Text].
-
Sato M and
Bremner I
(1993)
Oxygen free radicals and metallothionein.
Free Radical Biol Med
14:
325-337[Medline].
-
Satoh M,
Miura N,
Naganuma A,
Matsuzaki N,
Kawamura E and
Imura N
(1989)
Prevention of adverse effects of gamma-ray irradiation by metallothionein induction by bismuth subnitrate in mice.
Eur J Cancer Clin Oncol
25:
1727-1731[Medline].
-
Schwarz MA,
Lazo JS,
Yalowich JC,
Allen WP,
Whitmore M,
Bergonia HA,
Tzeng E,
Billiar TR,
Robbins PD,
Lancaster JR, Jr. and
Pitt BR.
(1995)
Metallothionein protects against the cytotoxic and DNA-damaging effects of nitric oxide.
Proc Natl Acad Sci
92:
4452-4456[Abstract/Free Full Text].
-
Searle PF,
Stuart GW and
Palmiter RD
(1985)
Building a metal-responsive promoter with synthetic regulatory elements.
Mol Cell Biol
5:
1480-1489[Abstract/Free Full Text].
-
Tanaka-Kagawa T,
Naganuma A and
Imura N
(1993)
Tubular secretion and reabsorption of mercury compounds in mouse kidney.
J Pharmacol Exp Ther
264:
776-782[Abstract/Free Full Text].
-
Thornalley PJ and
Vasak M
(1985)
Possible for metallothionein in protection against radiation-induced oxidative stress. Kinetics and mechanism of its reaction with superoxide and hydroxyl radicals.
Biochim Biophys Acta
827:
36-44[Medline].
-
Till JE and
McCulloch EA
(1961)
A direct measurement of the radiation sensitivity of normal mouse bone marrow cells.
Radiat Res
14:
213-222[Medline].
-
Webb M
(1979)
Metallothionein, in
The Chemistry, Biochemistry and Biology of Cadmium (Webb M ed) pp 195-266,
Elsevier/North Holland, Amsterdam.
0022-3565/98/2863-1427$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics